Bilfinger SE Earnings Calls
| Release date | Aug 12, 2026 |
| EPS estimate | $1.66 |
| EPS actual | - |
| Revenue estimate | 1.625B |
| Revenue actual | - |
| Expected change | +/- 9.50% |
| Release date | May 13, 2026 |
| EPS estimate | $1.24 |
| EPS actual | $1.20 |
| EPS Surprise | -3.23% |
| Revenue estimate | 1.503B |
| Revenue actual | 1.516B |
| Revenue Surprise | 0.88% |
| Release date | Mar 04, 2026 |
| EPS estimate | $1.86 |
| EPS actual | $1.70 |
| EPS Surprise | -8.60% |
| Revenue estimate | 1.602B |
| Revenue actual | 1.671B |
| Revenue Surprise | 4.29% |
| Release date | Nov 13, 2025 |
| EPS estimate | $1.64 |
| EPS actual | $1.72 |
| EPS Surprise | 4.88% |
| Revenue estimate | 1.573B |
| Revenue actual | 1.621B |
| Revenue Surprise | 3.03% |
Last 4 Quarters for Bilfinger SE
Below you can see how BFLBF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 13, 2025 |
| Price on release | $121.40 |
| EPS estimate | $1.64 |
| EPS actual | $1.72 |
| EPS surprise | 4.88% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $114.12 |
| Nov 10, 2025 | $121.40 |
| Nov 11, 2025 | $121.40 |
| Nov 12, 2025 | $121.40 |
| Nov 13, 2025 | $121.40 |
| Nov 14, 2025 | $114.12 |
| Nov 17, 2025 | $121.40 |
| Nov 18, 2025 | $121.40 |
| Nov 19, 2025 | $121.40 |
| 4 days before | 6.38% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 6.38% |
| Release date | Mar 04, 2026 |
| Price on release | $143.44 |
| EPS estimate | $1.86 |
| EPS actual | $1.70 |
| EPS surprise | -8.60% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $143.44 |
| Feb 27, 2026 | $143.44 |
| Mar 02, 2026 | $143.44 |
| Mar 03, 2026 | $143.44 |
| Mar 04, 2026 | $143.44 |
| Mar 05, 2026 | $143.44 |
| Mar 06, 2026 | $143.44 |
| Mar 09, 2026 | $143.44 |
| Mar 10, 2026 | $143.44 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | May 13, 2026 |
| Price on release | $117.00 |
| EPS estimate | $1.24 |
| EPS actual | $1.20 |
| EPS surprise | -3.23% |
| Date | Price |
|---|---|
| May 07, 2026 | $117.00 |
| May 08, 2026 | $117.00 |
| May 11, 2026 | $117.00 |
| May 12, 2026 | $117.00 |
| May 13, 2026 | $117.00 |
| May 14, 2026 | $117.00 |
| May 15, 2026 | $117.00 |
| May 18, 2026 | $117.00 |
| May 19, 2026 | $103.19 |
| 4 days before | 0% |
| 4 days after | -11.80% |
| On release day | 0% |
| Change in period | -11.80% |
| Release date | Aug 12, 2026 |
| Price on release | - |
| EPS estimate | $1.66 |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $103.19 |
| Aug 05, 2026 | $103.19 |
| Aug 06, 2026 | $103.19 |
| Aug 07, 2026 | $91.55 |
| Aug 10, 2026 | $91.55 |
Bilfinger SE Earnings Call Transcript Summary of Q1 2026
Key points for investors: 1) Q1 2026 results: revenue €1.3bn (+4% y/y), order intake -5%, order backlog +1%, EBITA margin 4.6% (up 10bps y/y), EPS €0.99 (up 17%), safety TRIF 0.69, cash flow €21m. 2) Guidance confirmed for 2026: revenue €5.4–5.9bn (management targets the midpoint), EBITA margin 5.8–6.2% and free cash flow €250–300m. Management expects activity to be back‑loaded into H2 due to severe winter weather impacts and geopolitical uncertainty (Middle East), which slowed customer decision timing rather than cancelled projects. 3) Working capital and cash flow were weak in Q1 due to invoicing delays from weather and Middle East disruptions (notably slowed admin/processes in the region); improvements are expected in Q2 and more materially in Q3. 4) Segment/industry notes: energy and biopharma are growth drivers (energy now ~26% of revenue, biopharma ~11%); chemicals/petrochem and parts of oil & gas show regional softness and smaller average order sizes. 5) M&A and strategic execution: Teknokon (Turkey) acquisition closed April 1 and will be included in guidance starting with the Q2 report; management continues to pursue M&A as a priority alongside organic investment and dividend growth. 6) Capital allocation: priority order is dividend growth, fund organic/M&A growth, then other shareholder returns; no new share buyback program planned at this time. 7) Balance sheet/liquidity: financial debt €178m; ~€150m of promissory loan note coming due end-June is being refinanced (company has engaged the market). 8) Innovation focus: digital tools (Bilfinger Client Portal 2.0 / AI scheduling for scaffolding) can materially reduce customer and execution costs and improve competitiveness.
Sign In
Buy BFLBF